251 related articles for article (PubMed ID: 35261783)
1. Intratumoral lymphatic endothelial cell infiltration reflecting lymphangiogenesis is counterbalanced by immune responses and better cancer biology in the breast cancer tumor microenvironment.
Wu R; Sarkar J; Tokumaru Y; Takabe Y; Oshi M; Asaoka M; Yan L; Ishikawa T; Takabe K
Am J Cancer Res; 2022; 12(2):504-520. PubMed ID: 35261783
[TBL] [Abstract][Full Text] [Related]
2. Abundance of reactive oxygen species (ROS) is associated with tumor aggressiveness, immune response, and worse survival in breast cancer.
Oshi M; Gandhi S; Yan L; Tokumaru Y; Wu R; Yamada A; Matsuyama R; Endo I; Takabe K
Breast Cancer Res Treat; 2022 Jul; 194(2):231-241. PubMed ID: 35639264
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral PDGFB gene predominantly expressed in endothelial cells is associated with angiogenesis and lymphangiogenesis, but not with metastasis in breast cancer.
Wu R; Gandhi S; Tokumaru Y; Asaoka M; Oshi M; Yan L; Ishikawa T; Takabe K
Breast Cancer Res Treat; 2022 Aug; 195(1):17-31. PubMed ID: 35793004
[TBL] [Abstract][Full Text] [Related]
4. Gastric cancer with enhanced myogenesis is associated with less cell proliferation, enriched epithelial-to-mesenchymal transition and angiogenesis, and poor clinical outcomes.
Chida K; Oshi M; An N; Kanazawa H; Roy AM; Mann GK; Yan L; Endo I; Hakamada K; Takabe K
Am J Cancer Res; 2024; 14(1):355-367. PubMed ID: 38323295
[TBL] [Abstract][Full Text] [Related]
5. High
Nelson ED; Benesch MG; Wu R; Ishikawa T; Takabe K
Am J Cancer Res; 2024; 14(1):227-242. PubMed ID: 38323277
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral density of regulatory T cells is a predictor of host immune response and chemotherapy response in colorectal cancer.
Oshi M; Sarkar J; Wu R; Tokumaru Y; Yan L; Nakagawa K; Ishibe A; Matsuyama R; Endo I; Takabe K
Am J Cancer Res; 2022; 12(2):490-503. PubMed ID: 35261782
[TBL] [Abstract][Full Text] [Related]
7. High miR-99b expression is associated with cell proliferation and worse patient outcomes in breast cancer.
Oshi M; Tokumaru Y; Benesch MG; Sugito N; Wu R; Yan L; Yamada A; Chishima T; Ishikawa T; Endo I; Takabe K
Am J Cancer Res; 2022; 12(10):4840-4852. PubMed ID: 36381329
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral Adipocyte-High Breast Cancer Enrich for Metastatic and Inflammation-Related Pathways but Associated with Less Cancer Cell Proliferation.
Tokumaru Y; Oshi M; Katsuta E; Yan L; Huang JL; Nagahashi M; Matsuhashi N; Futamura M; Yoshida K; Takabe K
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32796516
[TBL] [Abstract][Full Text] [Related]
9. Autotaxin production in the human breast cancer tumor microenvironment mitigates tumor progression in early breast cancers.
Benesch MG; Wu R; Tang X; Brindley DN; Ishikawa T; Takabe K
Am J Cancer Res; 2023; 13(7):2790-2813. PubMed ID: 37559999
[TBL] [Abstract][Full Text] [Related]
10. KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival.
Tokumaru Y; Oshi M; Katsuta E; Yan L; Satyananda V; Matsuhashi N; Futamura M; Akao Y; Yoshida K; Takabe K
Am J Cancer Res; 2020; 10(3):897-907. PubMed ID: 32266098
[TBL] [Abstract][Full Text] [Related]
11. Immune-interacting lymphatic endothelial subtype at capillary terminals drives lymphatic malformation.
Petkova M; Kraft M; Stritt S; Martinez-Corral I; Ortsäter H; Vanlandewijck M; Jakic B; Baselga E; Castillo SD; Graupera M; Betsholtz C; Mäkinen T
J Exp Med; 2023 Apr; 220(4):. PubMed ID: 36688917
[TBL] [Abstract][Full Text] [Related]
12. Lymphovascular invasion in breast cancer is associated with gene expression signatures of cell proliferation but not lymphangiogenesis or immune response.
Asaoka M; Patnaik SK; Zhang F; Ishikawa T; Takabe K
Breast Cancer Res Treat; 2020 Jun; 181(2):309-322. PubMed ID: 32285241
[TBL] [Abstract][Full Text] [Related]
13. High miR-200c expression is associated with suppressed epithelial-mesenchymal transition, TGF-β signaling and better survival despite enhanced cell proliferation in gastric cancer patients.
Shichiri K; Oshi M; Ziazadeh D; Endo I; Takabe K
Am J Cancer Res; 2023; 13(7):3027-3040. PubMed ID: 37560006
[TBL] [Abstract][Full Text] [Related]
14. Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression.
Harris AR; Perez MJ; Munson JM
BMC Cancer; 2018 Jul; 18(1):718. PubMed ID: 29976154
[TBL] [Abstract][Full Text] [Related]
15. Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients.
Zhao YC; Ni XJ; Li Y; Dai M; Yuan ZX; Zhu YY; Luo CY
World J Surg Oncol; 2012 Aug; 10():165. PubMed ID: 22906075
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Thermogenesis in Triple-Negative Breast Cancer Is Associated with Pro-Tumor Immune Microenvironment.
Gandhi S; Oshi M; Murthy V; Repasky EA; Takabe K
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34071012
[TBL] [Abstract][Full Text] [Related]
17. Inflammation Is Associated with Worse Outcome in the Whole Cohort but with Better Outcome in Triple-Negative Subtype of Breast Cancer Patients.
Oshi M; Newman S; Tokumaru Y; Yan L; Matsuyama R; Endo I; Takabe K
J Immunol Res; 2020; 2020():5618786. PubMed ID: 33457427
[TBL] [Abstract][Full Text] [Related]
18. Relationship of mast cell density with lymphangiogenesis and prognostic parameters in breast carcinoma.
Keser SH; Kandemir NO; Ece D; Gecmen GG; Gul AE; Barisik NO; Sensu S; Buyukuysal C; Barut F
Kaohsiung J Med Sci; 2017 Apr; 33(4):171-180. PubMed ID: 28359404
[TBL] [Abstract][Full Text] [Related]
19. Elevated bile acid metabolism and microbiome are associated with suppressed cell proliferation and better survival in breast cancer.
Wu R; Yu I; Tokumaru Y; Asaoka M; Oshi M; Yan L; Okuda S; Ishikawa T; Takabe K
Am J Cancer Res; 2022; 12(11):5271-5285. PubMed ID: 36504906
[TBL] [Abstract][Full Text] [Related]
20. Low intratumoral genetic neutrophil-to-lymphocyte ratio (NLR) is associated with favorable tumor immune microenvironment and with survival in triple negative breast cancer (TNBC).
Tokumaru Y; Oshi M; Murthy V; Tian W; Yan L; Angarita FA; Nagahashi M; Matsuhashi N; Futamura M; Yoshida K; Miyoshi Y; Takabe K
Am J Cancer Res; 2021; 11(11):5743-5755. PubMed ID: 34873491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
